Gene therapy is making great strides: Gene therapy involves the insertion of copies ofhealthy genes into a patient’s genetic code to counteract the effect of mutated or missing genes that can cause genetic disorders and illnesses. The genes can be injected directly into cells. The technique has courted controversy, and only received regulatory approval in the US in 2017 after years of research and development. It has mostly been used to help patients fighting cancer, but a version of the therapy recently developed by Bluebird Bio has shown some promise in curing a teenage boy in France of sickle cell disease. Meanwhile, another form of the treatment — known as Kymriah and Yescarta — has sent patients in the US with bone marrow cancer and lymphoma into long term remission.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
Why EGX stocks are going under the IPO wave
Fund managers are releasing liquidity for ongoing and future IPOs,…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…